Interojo Inc. (KOSDAQ:119610)
South Korea · Delayed Price · Currency is KRW 15,100
-130 (-0.85%)
Aug 12, 2026, 3:30 PM KST
Interojo Market Cap
Interojo has a market cap or net worth of 173.42 billion as of August 12, 2026. Its market cap has decreased by -19.76% in one year.
Market Cap
173.42B
Enterprise Value
192.01B
Revenue
126.03B
Ranking
n/a
PE Ratio
11.52
Stock Price
15,100.00
ChartMarket Cap Chart
Since July 28, 2010, Interojo's market cap has increased from 44.29B to 173.42B, an increase of 291.56%. That is a compound annual growth rate of 8.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2026 | 173.42B | -5.10% |
| Dec 30, 2025 | 182.73B | -53.77% |
| Dec 28, 2023 | 395.31B | 11.81% |
| Dec 29, 2022 | 353.55B | -0.83% |
| Dec 30, 2021 | 356.49B | 45.16% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 74.48T |
| Celltrion | 48.27T |
| ALTEOGEN | 22.80T |
| Samsung Epis Holdings | 10.59T |
| Hyundai Pharmaceutical | 177.14B |
| Daewon Pharmaceutical | 176.83B |
| AptaBio Therapeutics | 174.46B |
| DIO Corporation | 170.46B |